Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 21NIH 5INDUSTRY 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 10Lung Neoplasms 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Rectal Neoplasms 7Adenocarcinoma of Lung 7Colonic Neoplasms 5Adenocarcinoma, Bronchiolo-Alveolar 4Glioblastoma 3Brain Neoplasms 3Ovarian Neoplasms 2Neoplasm Metastasis 2Inflammatory Breast Neoplasms 2Gliosarcoma 2Carcinoma 2Breast Neoplasms, Male 2Unspecified Adult Solid Tumor, Protocol Specific 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Oligodendroglioma 1Non Small Cell Lung Cancer Metastatic 1Meningioma 1Medulloblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Glioma 1Fallopian Tube Neoplasms 1Erythema Multiforme 1Ependymoma 1Cognition Disorders 1

Interventions

Temozolomide 15Radiotherapy 12Lomustine 5Carboplatin 5Vincristine 4Carmustine 4Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Chemotherapy, Adjuvant 3lonafarnib 2imetelstat 2etoposide phosphate 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation 2Psychiatric Rehabilitation 2Procarbazine 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Irinotecan 2Drug Therapy 2vorasidenib 1veliparib 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1selinexor 1sargramostim 1palbociclib 1laromustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Astrocytoma × Bevacizumab × Clear all
NCT01164189 2019-02-28

TAVAREC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
155 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡